Enhancement of Mycophenolate Mofetil Permeation for Topical Use by Eucalyptol and N-Methyl-2-pyrrolidone
Mycophenolate mofetil (MMF) is a prodrug of mycophenolic acid (MPA) which can be metabolized by esterase. MMF has been approved by the United States Food and Drug Administration (USFDA) for treatment of psoriasis patient with skin symptoms. However, it remains unclear whether MMF is efficiently effe...
Main Authors: | Thanaporn Amnuaikit, Chalermkiat Songkram, Sirirat Pinsuwan |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Scientifica |
Online Access: | http://dx.doi.org/10.1155/2016/9672718 |
Similar Items
-
Mycophenolate mofetil and atherosclerosis
by: Z S Alekberova, et al.
Published: (2009-10-01) -
Mycophenolate mofetil in the treatment of lupus nephritis
by: Patrick FK Yong, et al.
Published: (2008-06-01) -
Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil induced gastrointestinal disorders
by: Sanaz Sheikhzadeh, et al.
Published: (2013-06-01) -
Prospects for using mycophenolate mofetil in diffuse scleroderma
by: L P Ananyeva
Published: (2009-03-01) -
Recalcitrant Esophageal Stricture Secondary to Mycophenolate Mofetil
by: Joyce J. Kim, et al.
Published: (2020-01-01)